SUSMED - Crossing the Borders: From Insider Knowledge to Disruptive Innovation
From struggles to entrepreneurship, how can the business model of SUSMED, which combines IT and medical research, work within existing frameworks while still driving changes for the medical system?
At a glance
Country
Japan
Industry
Healthcare
Establishment
2016
Operating revenue
US$ 3.6 million
Abstract
SUSMED, a Japanese healthcare company, has revolutionized the medical industry through innovative digital therapeutics (DTx) and advanced clinical trial solutions. Founded by Taro Ueno, a physician and researcher, SUSMED leverages technology to address pressing healthcare challenges, such as insomnia and cancer treatment.
By developing smartphone-based DTx applications, SUSMED offers effective and accessible treatment options for patients. The company's flagship product is a cognitive-behavioral therapy app for insomnia, designed to reduce reliance on sleeping pills. Additionally, SUSMED's blockchain-enabled clinical trial platform streamlines the drug development process, reducing costs and accelerating time-to-market.
This case study explores SUSMED's innovative business model, its commitment to patient-centric care, and its potential to reshape the global healthcare landscape. By combining medical expertise with cutting-edge technology, SUSMED aims to improve patient treatments and drive sustainable healthcare solutions.
All rights reserved. © 2025 Nikkei Business Lab Asia. No part of this publication may be copied, stored, or transmitted in any form. Copying or posting is an infringement of copyright.
Disclaimers:
(1) Regarding Case Study Content: This case study is based mainly on secondary data and analysis of publicly available information unless otherwise stated, and is intended solely for educational purposes. Any opinions expressed by the author(s) are designed to facilitate learning discussion and do not serve to illustrate the effectiveness of the company. Additionally, banner images and logos used in the case study are intended for visualization in an educational setting and it is not used to represent or brand the company. For any dispute regarding the content and usage of images and logos, please contact the team.
(2) Regarding University Affiliation and Titles of Authors: The university affiliation and titles of author(s) seen in the case study is based on their affiliation and title during the time of publication. It may or may not represent the current status of said author(s).